PROBE-PD
  • Sobre
  • Projeto
  • Equipe
  • Publicações
  • Parkinson
  • Contato
  • Português
    • Português
  • Home
Escolha uma Página

Mitochondrial complex I abnormalities underlie neurodegeneration and cognitive decline in Alzheimer’s disease.

por jcdadm.website | maio 1, 2022 | Publication

Terada T, Therriault J, Kang MS, Savard M, Pascoal TA, Lussier F, Tissot C, Wang YT, Benedet A, Poltronetti NM, Ottoy J, Arias JF, Bezgin G, Matsudaira T, Bunai T, Obi T, Tsukada H, Ouchi Y, Rosa-Neto P. Eur J Neurol. 2022 May;29(5):1324-1334. doi: 10.1111/ene.15246....

Preclinical in vivo longitudinal assessment of KG207-M as a disease-modifying Alzheimer’s disease therapeutic.

por jcdadm.website | maio 1, 2022 | Publication

Kang MS, Shin M, Ottoy J, Aliaga AA, Mathotaarachchi S, Quispialaya K, Pascoal TA, Collins DL, Chakravarty MM, Mathieu A, Sandelius Å, Blennow K, Zetterberg H, Massarweh G, Soucy JP, Cuello AC, Gauthier S, Waterston M, Yoganathan N, Lessard E, Haqqani A, Rennie K,...

Association of locus coeruleus integrity with Braak stage and neuropsychiatric symptom severity in Alzheimer’s disease.

por jcdadm.website | abr 1, 2022 | Publication

Cassidy CM, Therriault J, Pascoal TA, Cheung V, Savard M, Tuominen L, Chamoun M, McCall A, Celebi S, Lussier F, Massarweh G, Soucy JP, Weinshenker D, Tardif C, Ismail Z, Gauthier S, Rosa-Neto P. Neuropsychopharmacology. 2022 Apr;47(5):1128-1136. doi:...

A three-range approach enhances the prognostic utility of CSF biomarkers in Alzheimer’s disease.

por jcdadm.website | mar 13, 2022 | Publication

Brum WS, de Bastiani MA, Bieger A, Therriault J, Ferrari-Souza JP, Benedet AL, Saha-Chaudhuri P, Souza DO, Ashton NJ, Zetterberg H, Pascoal TA, Karikari T, Blennow K, Rosa-Neto P, Zimmer ER; Alzheimer’s Disease Neuroimaging Initiative (ADNI). Alzheimers Dement...

Comparing tau status determined via plasma pTau181, pTau231 and [18F]MK6240 tau-PET.

por jcdadm.website | fev 1, 2022 | Publication

Tissot C, Therriault J, Kunach P, L Benedet A, Pascoal TA, Ashton NJ, Karikari TK, Servaes S, Lussier FZ, Chamoun M, Tudorascu DL, Stevenson J, Rahmouni N, Poltronetti NM, Pallen V, Bezgin G, Kang MS, Mathotaarachchi SS, Wang YT, Fernandez Arias J, Ferreira PCL,...

Cerebrospinal fluid p-tau231 as an early indicator of emerging pathology in Alzheimer’s disease.

por jcdadm.website | fev 1, 2022 | Publication

Ashton NJ, Benedet AL, Pascoal TA, Karikari TK, Lantero-Rodriguez J, Brum WS, Mathotaarachchi S, Therriault J, Savard M, Chamoun M, Stoops E, Francois C, Vanmechelen E, Gauthier S, Zimmer ER, Zetterberg H, Blennow K, Rosa-Neto P. EBioMedicine. 2022 Feb;76:103836. doi:...
Página 3 de 14«12345...10...»Last »

Recent Posts

  • Genetic risk of ADHD may boost odds of Alzheimer’s in old age
  • Transcranial Direct Current Stimulation vs Sham for the Treatment of Inattention in Adults
  • Molecular Psychiatry: Astrocyte Biomarker Signatures of Amyloid-β and Tau Pathologies in Alzheimer’s Disease
  • Pitt Psychiatry Awarded $33.5M NIH Program Project Grant Focused on the Pathological and Clinical Progression of AD
  • Study Challenges Dogma Behind Alzheimer’s Disease Drug Trials

Website by